Texas Instruments
At a glance
Texas Instruments reported 2025 revenue of $17.68B, up 13% from $15.64B in 2024. Over 4 years since 2021 ($18.34B), that is a decline of about 0.9% a year. Operating margin was 34.1%, down from 48.8% in 2021. Revenue peaked in 2022 at $20.03B.
In the last 12 months 21 insiders reported 0 open-market purchases and 33 sales ($125.4M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $15.9M by Sr. Vice President & CFO Rafael R Lizardi on Feb 12, 2026.
Texas Instruments filed 10 current reports (Form 8-K) in the last 12 months, most often for results of operations (4), regulation fd disclosure (2), officer or director change (2) and shareholder vote results (1). The latest officer or director change was reported on Jun 2, 2026.
4 of the 20 investors tracked here held Texas Instruments at the last quarter end, worth $1.05B combined. It is the largest weight for Renaissance Technologies (0.6% of its portfolio), followed by National Pension Service (Korea) (0.4%). New this quarter: Soros Fund Management and Bridgewater Associates. Added: Renaissance Technologies.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $7.77B | $8.75B | $6.51B | $4.8B | $5B |
| Diluted EPS | $8.26 | $9.41 | $7.07 | $5.20 | $5.45 |
| Dividend per share | $4.21 | $4.69 | $5.02 | $5.26 | $5.50 |
Fiscal year ends Dec 31 · incorporated in DE
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined